Answers are grounded in this paper and cite their sources.
Cochrane Review assesses benefits and harms of tenecteplase versus alteplase in acute ischemic stroke, suggesting important health equity insights.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To assess the benefits and harms of tenecteplase compared to alteplase in people suffering from large vessel occlusion or non-large vessel occlusion acute ischemic stroke. Secondary objective To explore the effects of the interventions (tenecteplase and alteplase) in different groups based on age, sex, ethnicity, and place of residence (high-, middle-, low-income country), to inform health equity considerations.
No takes yet. Share an insight, caveat, or question.
Prabhakar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: